Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lisa Goto"'
Autor:
Lisa Goto, Olga Witkowska, Magdalena E Slusarczyk, Agnieszka M Grotek, Marek J Dziubinski, Bradley C Clark
Publikováno v:
Annals of Pediatric Cardiology, Vol 16, Iss 2, Pp 109-113 (2023)
Background: Palpitations are a frequent reason for referral to pediatric cardiology providers and diagnostic workup includes ambulatory cardiac monitoring. While common practice, the diagnostic yield is unknown in the pediatric population. The object
Externí odkaz:
https://doaj.org/article/3c276abb37dd411b93e7f157a9fd19a0
Autor:
Aiko Sueta, Masako Takeno, Lisa Goto-Yamaguchi, Mai Tomiguchi, Toko Inao, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-7 (2022)
Abstract Background Cowden syndrome is a rare autosomal-dominant disease with a high risk of malignant tumors of the breast, commonly caused by germline mutations in the PTEN gene. Most breast cancers related to Cowden syndrome showed typically a slo
Externí odkaz:
https://doaj.org/article/8ee2626e84824af794ce5c6fd793754c
Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
Autor:
Koichi Egashira, Daisuke Sueta, Masafumi Kidoh, Mai Tomiguchi, Seitaro Oda, Hiroki Usuku, Kaori Hidaka, Lisa Goto‐Yamaguchi, Aiko Sueta, Takashi Komorita, Fumi Oike, Koichiro Fujisue, Eiichiro Yamamoto, Shinsuke Hanatani, Seiji Takashio, Satoshi Araki, Kenichi Matsushita, Yutaka Yamamoto, Toshinori Hirai, Kenichi Tsujita
Publikováno v:
ESC Heart Failure, Vol 9, Iss 3, Pp 1792-1800 (2022)
Abstract Aims Understanding cardiac function after anthracycline administration is very important from the perspective of preventing the onset of heart failure. Although cardiac magnetic resonance and echocardiography are recognized as the ‘gold st
Externí odkaz:
https://doaj.org/article/f36114ce24004c46a20feaca5d87f166
Autor:
Koichi Egashira, Daisuke Sueta, Mai Tomiguchi, Masafumi Kidoh, Seitaro Oda, Hiroki Usuku, Kaori Hidaka, Lisa Goto-Yamaguchi, Aiko Sueta, Takashi Komorita, Masafumi Takae, Fumi Oike, Koichiro Fujisue, Eiichiro Yamamoto, Shinsuke Hanatani, Seiji Takashio, Yuichiro Arima, Satoshi Araki, Koichi Kaikita, Kenichi Matsushita, Yutaka Yamamoto, Toshinori Hirai, Kenichi Tsujita
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 34, Iss , Pp 100797- (2021)
Cardiotoxicity in the late phase after anthracycline drugs administration remains to be defined. Of the 44 patients who received anthracycline treatment, 7 were found to have cancer therapeutics–related cardiac dysfunction (CTRCD). The global longi
Externí odkaz:
https://doaj.org/article/51838850547b4b51a8ccb093770c80db
Autor:
Michelle Perez, Sara Soshnick, Lisa Goto, Gabrielle Jasmin, Joanne Anthonypillai, Gina Ramirez, Gina Cassel-Choudhury, Henry Ushay, Jacqueline Weingarten-Arams
Publikováno v:
Critical Care Medicine. 51:283-283
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b5c22a79b523008763d39fb64fb1317
https://doi.org/10.1097/01.ccm.0000908088.84808.60
https://doi.org/10.1097/01.ccm.0000908088.84808.60
Autor:
Koichi Egashira, Daisuke Sueta, Mai Tomiguchi, Kaori Hidaka, Lisa Goto-Yamaguchi, Aiko Sueta, Takashi Komorita, Masafumi Takae, Fumi Oike, Koichiro Fujisue, Hiroki Usuku, Eiichiro Yamamoto, Kenichi Matsushita, Yutaka Yamamoto, Kenichi Tsujita
Background: Anthracycline therapies cause myocardial damage and the onset of heart failure, depending on their doses. We investigated prognostic factors for cancer therapeutics-related cardiac dysfunction (CTRCD) in patients receiving modern anthracy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140a3e2e630deb21cf0dc0f5547efe77
https://doi.org/10.21203/rs.3.rs-1084573/v1
https://doi.org/10.21203/rs.3.rs-1084573/v1
Autor:
Lisa Goto-Yamaguchi, Yoshitaka Fujiki, Mai Tomiguchi, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Aiko Sueta, Hirotaka Iwase
Publikováno v:
Oncol Lett
Triple-negative breast cancer (TNBC) is characterized by aggressive clinicopathological features and is associated with a poor prognosis. Identifying patients that are non-responsive to chemotherapy remains a critical goal for effective personalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeabfdab7a002393ea1f1847bddf871c
https://doi.org/10.3892/ol.2021.13080
https://doi.org/10.3892/ol.2021.13080
Autor:
Aiko Sueta, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, Yoshitaka Fujiki, Lisa Goto-Yamaguchi, Hirotaka Iwase, Yutaka Yamamoto
Publikováno v:
Breast cancer (Tokyo, Japan). 29(2)
BRCAness is characterized as the phenotypes shared between some sporadic tumors and BRCA1/2 mutation cancers resulting in defective homologous recombination. The predictive or prognostic value of BRCAness in HER2-negative breast cancer patients who h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b883710ff32f51036048df0935d198
https://pubmed.ncbi.nlm.nih.gov/34985726
https://pubmed.ncbi.nlm.nih.gov/34985726
Autor:
Kaori Hidaka, Mai Tomiguchi, Eiichiro Yamamoto, Satoshi Araki, Fumi Oike, Koichiro Fujisue, Seiji Takashio, Masafumi Kidoh, Toshinori Hirai, Yuichiro Arima, Lisa Goto-Yamaguchi, Masafumi Takae, Hiroki Usuku, Seitaro Oda, Daisuke Sueta, Aiko Sueta, Kenichi Matsushita, Yutaka Yamamoto, Shinsuke Hanatani, Koichi Kaikita, Koichi Egashira, Takashi Komorita, Kenichi Tsujita
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 34, Iss, Pp 100797-(2021)
Cardiotoxicity in the late phase after anthracycline drugs administration remains to be defined. Of the 44 patients who received anthracycline treatment, 7 were found to have cancer therapeutics-related cardiac dysfunction (CTRCD). The global longitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e973f5bbc0e84be1a6b2378d6013daf9
http://www.sciencedirect.com/science/article/pii/S2352906721000853
http://www.sciencedirect.com/science/article/pii/S2352906721000853
Autor:
Yutaka Yamamoto, Aiko Sueta, Lisa Goto-Yamaguchi, Takashi Takeshita, Shi Qui, Hirotaka Iwase, Kaori Hidaka, Mai Tomiguchi, Ikuko Suzu
Publikováno v:
Breast cancer (Tokyo, Japan). 28(3)
HER2 (human epidermal growth factor receptor 2) status has been evaluated in breast cancer (BC) tissues by immunohistochemistry or in situ hybridization. We evaluated HER2 copy number (CN) assay in plasma cell-free DNA (cfDNA) from blood samples and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f76a635ac10798cfff25a1012e813dcd
https://pubmed.ncbi.nlm.nih.gov/33538993
https://pubmed.ncbi.nlm.nih.gov/33538993